Analysis of Drug Use of Anti-insomnia Therapy in Maintenance Hemodialysis Patients  

在线阅读下载全文

作  者:GAOCheng 

机构地区:[1]Tongling Hospital of Integrated Traditional Chinese and Western Medicine, Tongling Anhui 244151, China

出  处:《外文科技期刊数据库(文摘版)医药卫生》2022年第6期061-064,共4页

摘  要:Objective: to make statistics on the application of anti-insomnia drugs in maintenance hemodialysis patients, and compare and analyze the effectiveness and safety of different drugs, so as to promote clinical safe and rational drug use. Methods: 82 patients with maintenance hemodialysis who received anti insomnia drugs from January 2019 to June 2020 were retrospectively analyzed. They were divided into zolpidem group and estazolam group according to the different use of anti insomnia drugs. The relevant indicators during the treatment of corresponding anti insomnia drugs and after the withdrawal of drugs were compared and analyzed between the groups. Results: the average sleep time of zolpidem group was (22.68 ± 5.06) min, significantly shorter than that of estazolam group (44.33 ± 8.97) min (P < 0.05), and the average sleep time was (8.16 ± 1.37) h, significantly longer than that of estazolam group (6.96 ± 0.82)h (P < 0.05);The average PSQI score of zolpidem group was (10.00 ± 2.49) points, which was significantly lower than that of estazolam group (13.18 ± 1.68) min (P < 0.05);Compared with estazolam group, zolpidem group had a higher incidence of anterograde amnesia (40.54% vs 17.78%, P < 0.05), but the incidence of headache (13.51% vs 33.33%), drug resistance (29.73% vs 71.11%), hallucination (13.51% vs 33.33%), ataxia (5.41% vs 31.11%), and respiratory depression (0vs13.33%) was significantly higher than that of estazolam group (P < 0.05);The incidence of insomnia, anxiety and drug dependence in the zolpidem group was significantly lower than that in the estazolam group (32.43% vs 57.78%, 8.11% vs 53.33%, 10.81% vs 60.00%, P < 0.05). Conclusion: zolpidem is effective and highly safe in the treatment of insomnia in maintenance hemodialysis patients, which is worthy of wide clinical application.

关 键 词:MAINTAINABILITY HEMODIALYSIS anti-insomnia TREATMENT 

分 类 号:R[医药卫生]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象